Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Not Confirmed
Not Confirmed
04-07 July, 2025
Not Confirmed
Not Confirmed
07-11 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Not Confirmed
04-07 July, 2025
Industry Trade Show
Not Confirmed
07-11 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
10 Mar 2022
// PRESS RELEASE
https://media.bayer.de/baynews/baynews.nsf/id/Bayer-to-sell-its-Environmental-Science-Professional-business-to-Cinven-for-26-billion-US-dollars
17 Nov 2021
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/cinven-to-acquire-stake-bioagilytix/
19 Jul 2019
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/takeda-seeks-buyer-for-european-otc-off-patent-drugs-worth-eu1-5b-report
06 Sep 2017
// Carly Helfand FIERCE PHARMA
http://www.fiercepharma.com/pharma/bain-cinven-raise-stada-buyout-offer-again-under-activist-pressure
23 Aug 2017
// Phil Taylor PMLIVE
http://www.pmlive.com/pharma_news/stadas_4.1bn_takeover_goes_through_1202763
15 Aug 2017
// Phil Taylor PMLIVE
http://www.pmlive.com/pharma_news/time_running_out_on_new_stada_takeover_bid_1201979
Inspections and registrations
ABOUT THIS PAGE